Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Feb 7, 2024
S-1/A Feb 7, 2024
424B3 Feb 1, 2024
8-K Feb 1, 2024
UPLOAD Feb 1, 2024
S-1 Jan 29, 2024
424B3 Jan 23, 2024
EFFECT Jan 19, 2024
CORRESP Jan 17, 2024
CORRESP Jan 16, 2024
S-1/A Jan 16, 2024
UPLOAD Jan 10, 2024
8-K Jan 8, 2024
S-1/A Jan 8, 2024
CORRESP Jan 8, 2024
8-K Jan 5, 2024
4 Jan 4, 2024
4 Jan 4, 2024
4 Jan 4, 2024
4 Jan 4, 2024
4 Jan 4, 2024
4 Dec 26, 2023
UPLOAD Dec 21, 2023
8-K Dec 19, 2023
CORRESP Dec 12, 2023
← Newer Page 10 of 17 · 404 filings Older →